Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Postdoctoral Research, Walter Lab
Doctor of Philosophy (Ph.D.)
Bachelor of Arts (B.A.)
Doctor of Philosophy - PhD
Doctor of Philosophy - PhD
2023
2023
Investing in early stage companies at the intersection of science, engineering, and computation.
2023
2023
Building a completely new way to quickly structure, standardize, and clean healthcare and clinical data using AI.
2022
A leading venture investor in Cambridge backing and building category-leading deep tech and life sciences companies.
2021
2021
An automated platform to enable a richer understanding of individual cell behaviors, interactions, and functions across a range of stimuli and parameters, at massively parallel scale.
2019
2019
Committees: Chair Compensation, Member Audit Natera® is a worldwide genetic testing and diagnostics company that’s changing how doctors and patients manage genetic disease. Our team includes clinicians, scientists, biostatisticians, researchers, and talented laboratory professionals from around the globe.
2020
2020
Initiate partners with entrepreneurs to launch innovative companies built on bold ideas. We focus at the intersections of healthcare, life sciences and technology. Founder success is our success.
2014 - 2024
2014 - 2024
Independent board member Committees: Chair Compensation, Member Audit Evidation Health seeks to improve health outcomes through clinically and economically beneficial digital health solutions and new approaches to predictive analytics.
2017 - 2019
2017 - 2019
Led the J&J California team responsible for entrepreneurial ecosystem collaborations, deals and investments across Pharmaceutical, Medical Device and Consumer sectors. Drove deal structures including co-development, licensing, sponsored research and investment with negotiated terms ranging to >$1B.
2015 - 2018
2015 - 2018
Initially CEO, then board member. Acquired by Thorne (THRN) Drawbridge Health is focused on enabling personal diagnostic testing – anytime, anywhere with a people-friendly system for collecting and stabilizing blood samples
2014 - 2017
2015 - 2017
Managed team responsible for GE Ventures’ healthcare investing strategy, portfolio, venture partnerships and thought leadership. Oversaw creation of three new businesses, managed portfolio of >20 healthcare investments plus LP positions and portfolio company partnering. Member of GE Ventures investing committee, reviewing and approving investments and partnerships across GE verticals (energy, connected environments, iOT/digital, healthcare, advanced manufacturing).
2014 - 2015
Created new businesses for GE at intersection of data, consumer and healthcare. Internal entrepreneur forming companies as interim CEO from ground up - coordinating market analysis, business and operating plan, internal/external asset and IP negotiation, setting up structure and governance, financing, hiring and partnering strategy.